首页> 外文学位 >Design and synthesis of affinity chromatography ligands for the isolation of 5-HEDH enzyme: Synthesis of prostanoids and their identification in human urine.
【24h】

Design and synthesis of affinity chromatography ligands for the isolation of 5-HEDH enzyme: Synthesis of prostanoids and their identification in human urine.

机译:设计和合成用于分离5-HEDH酶的亲和色谱配体:类前列腺素的合成及其在人尿液中的鉴定。

获取原文
获取原文并翻译 | 示例

摘要

Arachidonic acid (AA) is converted to various biologically active metabolites by different pathways, the most important of which are initiated by 5-lipoxygenase (5-LO) and cyclooxygenase (COX). 5-LO oxidizes AA to 5-HpETE (5-hydroperoxy-6,8,11,14-eicosatetraenoic acid), which is either converted to the corresponding 5-hydroxy compound 5-HETE or to leukotrienes. 5-HETE, although possessing only weak biological activity itself, is oxidized to 5-oxo-ETE, a potent proinflammatory mediator. The actions of these 5-LO products are principally mediated by four highly selective receptors. We previously discovered the pathway leading to the formation of 5-oxo-ETE and showed that this substance is a potent chemoattractant for eosinophils and neutrophils. Although the 5-oxo-ETE receptor (i.e. the OXE receptor) was recently cloned, the physiological role of 5-oxo-ETE is not well understood, and the enzyme responsible for its formation (5-HEDH, 5-hydroxyeicosanoid dehydrogenase) has not yet been fully characterized or cloned. 5-HEDH is present in most types of inflammatory cells. Oxidation of 5-HETE to 5-oxo-ETE by this enzyme is limited by the availability of NADP+, which is normally present at very low concentrations in cells unless they are subjected to oxidative stress.;Our main goal was to determine how the biosynthesis of 5-oxo-ETE is regulated and to determine its pathophysiological roles. To achieve this task we designed and synthesized affinity chromatography ligands for the purification of the enzyme. Also, we designed and synthesized a series of 5-oxo-6E,8 Z-dienoic acids to study the requirements for the activation of 5-oxo-ETE receptor. This information will be helpful for the design and synthesis of inhibitors and agonists for this enzyme, as well as to synthesize 5-oxo-ETE receptor antagonist.*;Isoprostanes (iP) are products of free-radical peroxidation of arachidonic acid 5 (AA) and other polyunsaturated fatty acids (PUFA) such as arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). We have shown that the measurement of iPs in urine can be used as an index of the severity of inflammatory diseases such as Alzheimer's (AD) and atherosclerosis. We have proposed two mechanisms for the formation of iPs and have also proposed an in-depth nomenclature system for naming the isoprostanes.*;We wanted to develop a more efficient and general approaches to iPs and their intermediates, in particular to all-syn iPs. A new and stereoselective approach for the synthesis of all-syn iPs was established. This method is based on hydroboration using catechol borane and Wilkinson's catalyst. To demonstrate the usefulness of this approach, the first total synthesis of all-syn iP, 8,12-iso -iPE2alpha-III 187 was accomplished. Furthermore, this method can also be useful in the synthesis of another all-syn iP, 8,12- iso-iPD2alpha-III 188.;*Please refer to dissertation for diagrams.
机译:花生四烯酸(AA)通过不同的途径转化为各种具有生物活性的代谢物,其中最重要的是由5-脂氧合酶(5-LO)和环氧合酶(COX)引发的。 5-LO将AA氧化为5-HpETE(5-氢过氧-6,8,11,14-二十碳四烯酸),后者可转化为相应的5-羟基化合物5-HETE或白三烯。 5-HETE虽然本身仅具有较弱的生物活性,但会被氧化为5-oxo-ETE(一种有效的促炎介质)。这些5-LO产物的作用主要由四个高选择性受体介导。我们先前发现了导致5-oxo-ETE形成的途径,并表明该物质是嗜酸性粒细胞和嗜中性粒细胞的有效化学引诱剂。尽管最近克隆了5-oxo-ETE受体(即OXE受体),但对5-oxo-ETE的生理作用还不甚了解,并且负责其形成的酶(5-HEDH,5-羟基类花生酸脱氢酶)已经尚未完全鉴定或克隆。 5-HEDH存在于大多数类型的炎症细胞中。该酶将5-HETE氧化为5-oxo-ETE受NADP +可用性的限制,NADP +通常以非常低的浓度存在于细胞中,除非它们受到氧化应激。;我们的主要目标是确定如何进行生物合成调节5-oxo-ETE并确定其病理生理作用。为了完成此任务,我们设计并合成了亲和层析配体以纯化酶。此外,我们设计并合成了一系列5-oxo-6E,8 Z-二烯酸,以研究激活5-oxo-ETE受体的要求。该信息将有助于该酶的抑制剂和激动剂的设计和合成,以及合成5-oxo-ETE受体拮抗剂。*;异前列腺素(iP)是花生四烯酸5(AA)自由基过氧化的产物)和其他多不饱和脂肪酸(PUFA),例如花生四烯酸(AA),二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)。我们已经表明,尿液中iPs的测量可以用作炎症性疾病严重程度的指标,例如阿尔茨海默氏病(AD)和动脉粥样硬化。我们提出了两种形成iPs的机制,并且还提出了用于命名异前列腺素的深入命名系统。*;我们想为iPs及其中间体(尤其是全同位iPs)开发一种更有效,更通用的方法。建立了一种合成全合成iP的新的立体选择性方法。该方法基于使用邻苯二酚硼烷和威尔金森氏催化剂的硼氢化反应。为了证明这种方法的实用性,完成了全合成iP 8,12-iso -iPE2alpha-III 187的首次全合成。此外,该方法还可用于合成另一种全同型iP,8,12-异-iPD2α-III188。*请参考论文的图表。

著录项

  • 作者

    Patel, Pranav.;

  • 作者单位

    Florida Institute of Technology.;

  • 授予单位 Florida Institute of Technology.;
  • 学科 Chemistry Organic.;Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 320 p.
  • 总页数 320
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 有机化学;药物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号